If you have CCSVI, your chance of a quick, successful, drug-free treatment is over 50%. But DO you, in fact, have CCSVI?

In other words, is there some kind of blockage of your jugular and/or azygus veins that would be triggering an MS-type condition? Of course you can’t know until you’re tested and there’s the catch: Not only is this condition being ignored by neurologists and other MS professionals, but it’s actually illegal to be tested for a CCSVI condition in the U.S. and in Canada! At the present time, you’ll have to go abroad to be tested and treated.

Does that make any sense?

Here’s some background on Chronic Cerebro-Spinal Venous Insufficiency
(CCSVI).

MS is an “industry” that does well over $10 billion a year in commercial transactions, and that means some very powerful interests have a strong interest in maintaining the status quo. The pharmaceutical industry, alone, does over $8 billion a year world-wide in selling MS drugs and that figure will grow to $15 billion in four years..

Within the medical community, prominent neurologists comprise a powerful vested interest, along with the various MS societies through the U.S. and Canada. They employ a vast number of people who have based their careers on helping MS patients “control” their disease. Trouble is, ”control” is not and will never be a CURE. And that’s why these people, for a variety of reasons,have become blinded to fresh thinking and are fighting to maintain the status quo.

Even though an increasing number of MS patients are being successfully treated for CCSVI – so far, just a tiny trickle – there is much to be learned about the implications and long-term treatment of CCSVI for Multiple Sclerosis. And for that matter, could it affect other diseases.

• Over 50% MS patients have CCSVI – probably in the range of 60% - 70%.

• We know that blocked veins are an abnormality for ANY condition, and this is what CCSVI is all about.

One might think that with something as large and important as Multiple Sclerosis, there would be a uniformity of purpose among all the parties concerned. After all, shouldn’t everyone agree that finding a cure is all that counts – and there should be no room for hidden agendas or individual self-interest and financial gain? One might think so, but that’s not the case.

All too often, when entrenched interests try to block something radically new, the innovative pioneers are treated very poorly and often slighted and slandered – or just ignored. So it is with Dr. Paolo Zamboni, with the original groundbreaking research being done by Dr. Franz Schelling of Austria. Here’s some background on the people who may eventually be awarded the Nobel Prize for Medicine.